Editas officer plans sale of 700 EDIT shares

Editas Medicine, Inc. (EDIT) has a notice under Rule 144 filed by officer Linda C. Burkly covering potential sales of the company’s common stock.

Rhea-AI Filing Summary

Editas Medicine, Inc. (EDIT) has a notice under Rule 144 filed by officer Linda C. Burkly covering potential sales of the company’s common stock. The notice lists 700 shares of common stock held at ETrade, with a stated aggregate value of $2,296.00 and a proposed sale date of 09/03/2026. It also notes that additional shares to be sold are tied to Restricted Stock Unit vesting from issuer equity compensation on 09/02/2026 and discloses prior sales in the last three months.

Key Figures

Shares covered in main notice: 700 shares of Common Stock Aggregate value of main notice shares: $2,296.00 Past 3 months sale on 06/03/2026: 731 shares for $1,974.50 +2 more

5 metrics

Shares covered in main notice 700 shares of Common Stock Listed in securities information section with proposed sale date 09/03/2026

Aggregate value of main notice shares $2,296.00 Aggregate value for 700 shares of common stock

Past 3 months sale on 06/03/2026 731 shares for $1,974.50 Common stock sold by Linda C. Burkly during past 3 months

Past 3 months sale on 07/28/2026 4,928 shares for $13,157.76 Common stock sold by Linda C. Burkly during past 3 months

Vesting date for equity compensation 09/02/2026 Restricted Stock Unit Vesting from issuer equity compensation

Key Terms

Rule 144, Restricted Stock Unit Vesting, Equity Compensation

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Unit Vesting financial

"Common Stock | 09/02/2026 | Restricted Stock Unit Vesting | Issuer"

Equity Compensation financial

"1550 | 09/02/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for Editas Medicine, Inc. (EDIT)?

The Form 144 indicates that officer Linda C. Burkly has notified of her intent to sell shares of Editas Medicine, Inc. common stock under Rule 144, including 700 shares with an aggregate value of $2,296.00, subject to Rule 144 conditions.

How many EDIT shares are covered by Linda C. Burkly’s current Form 144 notice?

The notice lists 700 shares of Editas Medicine, Inc. common stock in the main securities information section and also references additional shares deliverable from Restricted Stock Unit vesting associated with issuer equity compensation on 09/02/2026.

What prior sales of EDIT stock has Linda C. Burkly reported in the last three months?

The filing reports that Linda C. Burkly sold 731 shares of common stock on 06/03/2026 for total proceeds of $1,974.50 and 4,928 shares on 07/28/2026 for total proceeds of $13,157.76.

What is the proposed sale date for the EDIT shares in this Form 144?

The securities information section identifies a proposed sale date of 09/03/2026 for the 700 shares of Editas Medicine, Inc. common stock referenced in the notice.

What is the source of the additional EDIT shares mentioned in the Form 144?

The additional shares are tied to Restricted Stock Unit Vesting from Equity Compensation provided by the issuer, Editas Medicine, Inc., with a vesting date listed as 09/02/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 04:10 PM EDT Accepted by SEC EDGAR 08/31/2026 - 04:09 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001985604
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Editas Medicine, Inc.
SEC File Number	001-37687
Address of Issuer	11 HURLEY ST. CAMBRIDGE MASSACHUSETTS 02141
Phone	617-401-9000
Name of Person for Whose Account the Securities are To Be Sold	Burkly Linda
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETrade Corporation 3 Edison Financial Alphareta GA 30005	700	2296.00	153580035	09/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/02/2026	Restricted Stock Unit Vesting	Issuer			1550	09/02/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Linda C. Burkly 11 Hurley Street Cambridge MA 02141	Common Stock	06/03/2026	731	1974.50
Linda C. Burkly 11 Hurley Street Cambridge MA 02141	Common Stock	07/28/2026	4928	13157.76

144: Remarks and Signature

Remarks
Date of Notice	08/31/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/03/2023
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Linda C. Burkly
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)